This report, recently published in Annals of Internal Medicine, represents the second update of a previously published living systematic review (Hernandez AV, Roman YM, Pasupuleti V, et al. Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19.

he objective of this randomised, open-label trial, recently published in JAMA, was to determine the efficacy of 5 or 10 days of remdesivir treatment compared with standard care on clinical status on day 11 after initiation of treatment in patients with moderate COVID-19 infection.

In this prospective study, the authors aimed to identify the existence of potential brain microstructural changes related to SARS-CoV-2 infection.

The aim of this study, recently published in the Journal of Neurology, Neurosurgery and Psychiatry was, by a systematic review of the reported cases of GBS in SARS-CoV-2 infection, to clarify the clinical and electrophysiological phenotype, to discuss, on the basis of the available data, whether the disease mechanism could be parainfective or postinfective and to speculate on the possible pathogenesis.

In this multicentre retrospective observational cohort study recently published in Lancet Rheumatology, the authors investigate the association between tocilizumab exposure and hospital-related mortality among patients requiring intensive care unit (ICU) support for COVID-19.

Rapid and accurate diagnostic tests are essential for controlling the ongoing Covid-19 pandemic.

In this report from Budapest, Hungary, the authors compared several clinical features (including time parameters, rate of intravenous thrombolysis and endovascular therapies) of patients admitted to a university stroke-unit within a 2-month COVID-pandemic period (March and April of 2020) with an identical pre-COVID period of 2019.

The EBC releases its 2019 Annual Report

For September 2020, we have selected: The RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report.

EAN signed a Memorandum of Understanding with the WBP – Women’s Brain Project joining forces to promote optimal cooperation in Europe between both societies.

David Vodušek, Chair of the EAN European Affairs sub-Committee interviews Wolfgang H. Oertel, member of the European Commission’s Scientific Panel for Health

Matthias Endres, new Member at Large By Matthias Endres Dear Colleagues and Friends, It is indeed a great honour for me to be elected as a new Member-at-Large of the EAN board. Especially in these times of great uncertainty both… Continue Reading

For September 2020, we have selected two complementary papers.

Kazakhstan, officially the Republic of Kazakhstan (Kazakh: Қазақстан Республикасы), is located in the centre of the Eurasian continent.

The European Brain Research Area project – EBRA – was created as a catalyzing platform for brain research stakeholders (researchers, clinicians, patients, governments, funders and public institutions) to streamline and better coordinate brain research across Europe.